MOSCOW, June 29 (Reuters) – Russia’s Sputnik V COVID-19 vaccine is around 90% effective against the highly contagious Delta variant of the coronavirus, its developers announced on Tuesday.
The vaccine, which Russia has actively marketed overseas, has already been found by researchers to be nearly 92% effective against the original strain of coronavirus.
Denis Logunov, deputy director of the Gamaleya Institute in Moscow that developed Sputnik V, said the efficacy figure for the Delta variant was calculated based on digital medical and vaccine records, the news agency reported. RIA.
Russian authorities have blamed a recent increase in COVID-19 cases on the infectious variant Delta, which they say accounts for around 90% of all new cases, and the reluctance of many Russians to get vaccinated.
Countries around the world have sounded the alarm bells regarding the Delta variant, according to Alexander Gintsburg, director of the Gamaleya Institute.
In one case, the share of COVID-19 cases caused by the Delta variant more than doubled in Germany in one week and is expected to gain popularity compared to other variants, a senior health official said on Monday. Read more
Russia, which has a population of around 144 million, has approved four domestically-made vaccines and recorded some 5.5 million infections since the start of the pandemic.
Reporting by Anton Kolodyazhnyy; Writing by Gabrielle Tétrault-Farber; Editing by Catherine Evans
Our Standards: The Thomson Reuters Trust Principles.